K
8.49
0.01 (0.12%)
| Penutupan Terdahulu | 8.48 |
| Buka | 8.53 |
| Jumlah Dagangan | 1,564,410 |
| Purata Dagangan (3B) | 1,511,703 |
| Modal Pasaran | 738,778,752 |
| Harga / Jualan (P/S) | 9.58 |
| Harga / Buku (P/B) | 2.60 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Feb 2026 |
| Margin Keuntungan | -267.52% |
| Margin Operasi (TTM) | -458.61% |
| EPS Cair (TTM) | -2.09 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 5.31% |
| Nisbah Semasa (MRQ) | 8.07 |
| Aliran Tunai Operasi (OCF TTM) | 111.23 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -95.01 M |
| Pulangan Atas Aset (ROA TTM) | -19.60% |
| Pulangan Atas Ekuiti (ROE TTM) | -41.84% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Kura Oncology, Inc. | Menaik | Menaik |
AISkor Stockmoo
0.6
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | -2.0 |
| Purata | 0.63 |
|
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company’s pipeline consists of small molecule drug candidates targeting cancer signaling pathways. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.09% |
| % Dimiliki oleh Institusi | 93.89% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Alethea Capital Management, Llc | 31 Dec 2025 | 1,422,682 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 40.00 (HC Wainwright & Co., 371.14%) | Beli |
| Median | 30.00 (253.36%) | |
| Rendah | 20.00 (Leerink Partners, 135.57%) | Beli |
| Purata | 30.00 (253.36%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 9.21 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 13 Jan 2026 | 40.00 (371.14%) | Beli | 9.21 |
| Leerink Partners | 13 Jan 2026 | 20.00 (135.57%) | Beli | 9.21 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |